Arik Ben Ishay

Expand U.S. operations and pursue regulatory approvals by 2026 Biobeat

TRUST SCORE
0%
1
Total
0
Broken
0
Kept
1
Pending

Promises

Arik Ben Ishay

Tech & Product

PENDING
"Biobeat CEO Arik Ben Ishay promised to use new capital to expand U.S. operations and pursue broader regulatory approvals for their continuous blood pressure monitoring device by en..."
Made: Jan 6, 2026 269 days left
8 0